J&J’s TachoSil Deal Dropped on Antitrust Issues; Takeda Mum on Future Plan

April 16, 2020
Takeda Pharmaceutical’s plan to divest TachoSil surgical patch to Ethicon, a unit of Johnson & Johnson, has been blocked due to antitrust concerns, according to the US Federal Trade Commission. The Japanese pharma giant remains silent on its future plan...read more